ArticleCardiovascular and interventional radiology2026
Long-Term Outcomes of Uterine Artery Embolization for Treatment of Fibroids in Women Under 40: A Retrospective Survey Study at Two Institutions with Median 16-year Follow-up.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess long-term freedom from symptom recurrence and success of entering menopause without hysterectomy for patients younger than 40 years old undergoing uterine fibroid embolization (UFE). MATERIALS AND
methodsWomen under 40 who underwent UFE from 2001-2012 at two institutions and who participated in a telephone survey in 2024 were included. The survey assessed symptom response to UFE, need for additional procedures, and patient satisfaction with UFE.
results976 women underwent UFE; of these, 173 were younger than 40 at the time of UFE, and 80 of 173 (46.2%) participated in the survey. Median age at embolization was 37.2 (range 26.4-39.8) and when surveyed was 52.7 (range 43.1-61.9). 70.0% (56/80) and 18.8% (15/80) of patients reported "a lot" or "a little" symptom improvement, respectively, in the first 6 months after UFE; 11.2% (9/80) reported no change. Of those with improvement, symptoms returned in 57.7% (41/71) with median time to recurrence of 11.0 years (range 0.5-20 years). Freedom from recurrence of symptoms was 68/71 (95.8%) at 1 year, 48/71 (67.6%) at 5 years, and 36/71 (50.7%) at 10 years. Freedom from hysterectomy for recurrent symptoms was 70/71 (98.6%) at 1 year, 60/71 (84.5%) at 5 years, and 51/71 (71.8%) at 10 years. Patient satisfaction with having UFE was a median of 5 on a scale of 1-5 (5 = very satisfied).
conclusionWomen under 40 who undergo UFE are likely to experience return of symptoms before menopause and may require additional procedures, yet they remain highly satisfied with the procedure. LEVEL OF EVIDENCE: Level 4, Case Series.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.